Formosa Laboratories Statistics

Total Valuation

Formosa Laboratories has a market cap or net worth of TWD 11.02 billion. The enterprise value is 13.40 billion.

Market Cap	11.02B
Enterprise Value	13.40B

Important Dates

The next estimated earnings date is Friday, November 8, 2024.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	Aug 13, 2024

Share Statistics

Formosa Laboratories has 120.26 million shares outstanding. The number of shares has decreased by -0.54% in one year.

Shares Outstanding	120.26M
Shares Change (YoY)	-0.54%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	10.36%
Owned by Institutions (%)	28.74%
Float	97.21M

Valuation Ratios

The trailing PE ratio is 43.04 and the forward PE ratio is 14.63.

PE Ratio	43.04
Forward PE	14.63
PS Ratio	2.35
PB Ratio	1.47
P/FCF Ratio	27.70
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.79, with an EV/FCF ratio of 33.68.

EV / Earnings	52.34
EV / Sales	2.86
EV / EBITDA	10.79
EV / EBIT	18.02
EV / FCF	33.68

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.46.

Current Ratio	1.82
Quick Ratio	1.13
Debt / Equity	0.46
Debt / EBITDA	3.02
Debt / FCF	9.38
Interest Coverage	17.34

Financial Efficiency

Return on equity (ROE) is 1.17% and return on invested capital (ROIC) is 3.84%.

Return on Equity (ROE)	1.17%
Return on Assets (ROA)	3.42%
Return on Capital (ROIC)	3.84%
Revenue Per Employee	16.75M
Profits Per Employee	914,068
Employee Count	280
Asset Turnover	0.35
Inventory Turnover	1.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.20% in the last 52 weeks. The beta is 0.76, so Formosa Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	+10.20%
50-Day Moving Average	93.98
200-Day Moving Average	100.60
Relative Strength Index (RSI)	44.46
Average Volume (20 Days)	947,590

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Formosa Laboratories had revenue of TWD 4.69 billion and earned 255.94 million in profits. Earnings per share was 2.13.

Revenue	4.69B
Gross Profit	2.08B
Operating Income	737.20M
Pretax Income	288.50M
Net Income	255.94M
EBITDA	1.21B
EBIT	737.20M
Earnings Per Share (EPS)	2.13

Full Income Statement

Balance Sheet

The company has 1.93 billion in cash and 3.73 billion in debt, giving a net cash position of -1.80 billion or -14.96 per share.

Cash & Cash Equivalents	1.93B
Total Debt	3.73B
Net Cash	-1.80B
Net Cash Per Share	-14.96
Equity (Book Value)	8.10B
Book Value Per Share	62.49
Working Capital	2.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 962.62 million and capital expenditures -564.92 million, giving a free cash flow of 397.70 million.

Operating Cash Flow	962.62M
Capital Expenditures	-564.92M
Free Cash Flow	397.70M
FCF Per Share	3.31

Full Cash Flow Statement

Margins

Gross margin is 44.30%, with operating and profit margins of 15.72% and 5.46%.

Gross Margin	44.30%
Operating Margin	15.72%
Pretax Margin	6.15%
Profit Margin	5.46%
EBITDA Margin	25.73%
EBIT Margin	15.72%
FCF Margin	8.48%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.16%.

Dividend Per Share	2.00
Dividend Yield	2.16%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	n/a
Payout Ratio	46.99%
Buyback Yield	0.54%
Shareholder Yield	2.71%
Earnings Yield	2.32%
FCF Yield	3.61%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Formosa Laboratories has an Altman Z-Score of 2.35. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.35
Piotroski F-Score	n/a